{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:02:01Z","timestamp":1771261321584,"version":"3.50.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,13]]},"abstract":"<jats:p>\n                    Differentiated thyroid carcinoma (DTC) frequently requires radioactive iodine therapy, yet accurately predicting short-term therapeutic response remains challenging. Radiomics offers a means to quantify intratumoral heterogeneity from routine imaging. We aimed to develop and internally validate a Single-photon emission computed tomography (SPECT)-based radiomics nomogram for predicting 6-month response after RAI in DTC. We conducted a single-center retrospective study of 420 patients with DTC. Post-therapy\n                    <jats:sup>131<\/jats:sup>\n                    I SPECT\/CT images were processed to extract image biomarker standardisation initiative-aligned radiomic features in MATLAB; features passing reproducibility (ICC\u2005\u2265\u20050.80) and redundancy (|\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    |&lt;0.85) filters were entered into a nested-cross-validation (CV) least absolute shrinkage and selection operator to derive a radiomics score, which was combined with clinicopathologic variables to build a nomogram. Model performance was assessed for discrimination (receiver operating characteristic area under the curve [AUC]), calibration (concordance index [C-index]; calibration intercept\/slope), and clinical utility (decision-curve analysis); internal validation used outer 10-fold CV and 1000 bootstrap with permutation testing. Multicollinearity was checked by variance inflation factor. Interobserver reproducibility was high: 79\/107 (73.8%) features achieved ICC\u2005\u2265\u20050.80 (median ICC 0.88), and the median mask-level Dice was 0.87. The nomogram showed AUC\u2005=\u20050.853 (95% confidence interval: 0.786\u20130.892) and C-index\u2005=\u20050.889 (95% confidence interval: 0.812\u20130.934) with good calibration. Internal validation yielded CV\u2013AUC\u2005=\u20050.846 (SD 0.037) and bootstrap optimism-corrected C-index\u2005=\u20050.876\/AUC\u2005=\u20050.848; permutation AUCs centered near 0.50. Decision-curve analysis indicated clinical net benefit across thresholds 0.15 to 0.95. All validation was internal; no external cohort was available. Radiomics score, age, regional lymph node metastasis, extrathyroidal extension, and tumor diameter independently influence the therapeutic outcome of RAI in DTC patients. In this exploratory, single-center study, the SPECT-based radiomics nomogram demonstrates promising internal performance; however, it must undergo external, multi-center validation and, if necessary, local recalibration before it can be considered for routine clinical use.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047658","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:00:26Z","timestamp":1771005626000},"page":"e47658","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Construction and evaluation of a SPECT-based radiomics nomogram for predicting the therapeutic response to radioactive iodine in patients with differentiated thyroid carcinoma"],"prefix":"10.1097","volume":"105","author":[{"given":"Haiyang","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Radiology, Yanbian University Affiliated Hospital (Yanbian Hospital), Yanji, Jilin Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7476-8150","authenticated-orcid":false,"given":"Yingnan","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Southeast University Affiliated Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peihui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neuro-Intervention, Huludao Central Hospital, Huludao, Liaoning Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260216","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20260216","first-page":"19","article-title":"Analysis of malignant tumor epidemiology in China, 2015.","volume":"41","author":"Zheng","year":"2019","journal-title":"Chin J Oncol"},{"key":"R3-20260216","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1200\/JCO.21.01841","article-title":"Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies.","volume":"40","author":"Pasqual","year":"2022","journal-title":"J Clin Oncol"},{"key":"R4-20260216","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2214\/AJR.19.22626","article-title":"Radioactive iodine therapy in differentiated thyroid cancer: 2020 update.","volume":"215","author":"Ciarallo","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"R5-20260216","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12020-021-02737-7","article-title":"Usefulness of 123I-SPECT\/CT to assess the response to initial therapy in differentiated thyroid cancer patients.","volume":"74","author":"Campenn\u00ec","year":"2021","journal-title":"Endocrine"},{"key":"R6-20260216","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12880-021-00612-5","article-title":"The clinical significance of remnant thyroid tissue in thyroidectomized differentiated thyroid cancer patients on 131I-SPECT\/CT.","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Med Imaging"},{"key":"R7-20260216","doi-asserted-by":"crossref","first-page":"849065","DOI":"10.3389\/fendo.2022.849065","article-title":"Radiomics analysis of computed tomography for prediction of thyroid capsule invasion in papillary thyroid carcinoma: a multi-classifier and two-center study.","volume":"13","author":"Wu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R8-20260216","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1016\/j.acra.2024.03.012","article-title":"Ultrasound-based radiomics for discerning lymph node metastasis in thyroid cancer: a systematic review and meta-analysis.","volume":"31","author":"Zhang","year":"2024","journal-title":"Acad Radiol"},{"key":"R9-20260216","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3390\/cancers15051613","article-title":"Clinical-radiomics nomogram based on contrast-enhanced ultrasound for preoperative prediction of cervical lymph node metastasis in papillary thyroid carcinoma.","volume":"15","author":"Jiang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R10-20260216","first-page":"1164","article-title":"Guidelines of Chinese Society of Clinical Oncology (CSCO) differentiated thyroid cancer.","volume":"34","year":"2021","journal-title":"J Cancer Control Treat"},{"key":"R11-20260216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer.","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"R12-20260216","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1210\/jc.2017-01790","article-title":"Second radioiodine treatment: limited benefit for differentiated thyroid cancer with locoregional persistent disease.","volume":"103","author":"Hirsch","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20260216","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1007\/s00259-022-05762-4","article-title":"Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma-a critical review and evaluation of the existing evidence.","volume":"49","author":"Reinecke","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R14-20260216","first-page":"1184","article-title":"Dabrafenib versus dabrafenib plus trametinib in BRAF-mutated radioactive iodine-refractory differentiated thyroid cancer: results of a randomized, phase 2, open-label multicenter trial.","volume":"32","author":"Busaidy","year":"2022","journal-title":"Thyroid"},{"key":"R15-20260216","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3803\/EnM.2019.34.3.215","article-title":"Radioactive iodine-refractory differentiated thyroid cancer and redifferentiation therapy.","volume":"34","author":"Liu","year":"2019","journal-title":"Endocrinol Metab (Seoul)"},{"key":"R16-20260216","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1038\/s41598-024-55755-6","article-title":"Combined clinical variables and radiomics of post-treatment I-131 total-body scan for prediction of successful ablation in low-risk papillary thyroid carcinoma patients.","volume":"14","author":"Chantadisai","year":"2024","journal-title":"Sci Rep"},{"key":"R17-20260216","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/jamaoncol.2021.6268","article-title":"Apatinib vs placebo in patients with locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: the REALITY randomized clinical trial.","volume":"8","author":"Lin","year":"2022","journal-title":"JAMA Oncol"},{"key":"R18-20260216","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1186\/s12967-024-05896-z","article-title":"Association of radiomic features with genomic signatures in thyroid cancer: a systematic review.","volume":"22","author":"Luciano","year":"2024","journal-title":"J Transl Med"},{"key":"R19-20260216","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1038\/s41598-023-31212-8","article-title":"Contrast-enhanced CT-based radiomics for the differentiation of anaplastic or poorly differentiated thyroid carcinoma from differentiated thyroid carcinoma: a pilot study.","volume":"13","author":"Moon","year":"2023","journal-title":"Sci Rep"},{"key":"R20-20260216","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/EJE-21-0365","article-title":"The influence of age on disease outcome in 2015 ATA high-risk differentiated thyroid cancer patients.","volume":"185","author":"van Velsen","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"R21-20260216","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/cancers11091230","article-title":"Predictive factors of recurrence in patients with differentiated thyroid carcinoma: a retrospective analysis on 579 patients.","volume":"11","author":"Medas","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R22-20260216","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41574-020-00448-z","article-title":"Current practice in patients with differentiated thyroid cancer.","volume":"17","author":"Schlumberger","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"R23-20260216","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1210\/jc.2019-00177","article-title":"Risk stratification in differentiated thyroid cancer: from detection to final follow-up.","volume":"104","author":"Tuttle","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20260216","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1210\/clinem\/dgae364","article-title":"Prognostic analysis of I-131 efficacy after papillary thyroid carcinoma surgery based on CT radiomics.","volume":"109","author":"Cao","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-20260216","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40644-024-00664-0","article-title":"Correlation between remnant thyroid gland I-131 uptake and serum thyroglobulin levels: can we rely on I-131 whole-body scans?","volume":"24","author":"Hwang","year":"2024","journal-title":"Cancer Imaging"},{"key":"R26-20260216","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.3390\/jcm13071984","article-title":"Pre-treatment and post-treatment I131 imaging in differentiated thyroid carcinoma.","volume":"13","author":"Mihailovi\u0107","year":"2024","journal-title":"J Clin Med"},{"key":"R27-20260216","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12957-024-03566-4","article-title":"Meta-analysis of prediction models for predicting lymph node metastasis in thyroid cancer.","volume":"22","author":"Liu","year":"2024","journal-title":"World J Surg Oncol"},{"key":"R28-20260216","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12885-024-11838-1","article-title":"An integrated model incorporating deep learning, hand-crafted radiomics and clinical and US features to diagnose central lymph node metastasis in papillary thyroid cancer.","volume":"24","author":"Gao","year":"2024","journal-title":"BMC Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:01:53Z","timestamp":1771257713000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047658","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"2025-06-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}